[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566843":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":72,"collaborators":12,"id":74,"slug":12,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":12,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":12,"enrollmentInfo":82,"targetDuration":12,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":61,"whyStopped":12,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Biogipuzkoa Health Research Institute","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Group","NO_INTERVENTION","The control group will receive the usual care and indications.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention Group","EXPERIMENTAL","The interventional group will add a exercise program.",[18],"Other: Exercise",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Exercise","The lymphoma unit of the Donostia University Hospital (HUD) is part of the Onkofrail project that analyzes the impact of a physical activity in older cancer patients. The Onkofrail study has included everything type of solid tumors and very diverse treatments, which is a limitation methodology that could condition the analysis of the results. Therefore, the need of proposing a new PE project in a homogeneous population such as that of people with lymphoma, the most prevalent hemopathy in our environment, which has a great survival, but present important adverse effects secondary to treatment systemic.",[14],[25],{"name":26,"affiliation":27,"role":28},"Izaskun Zeberio Etxetxipia","Hospital Donostia","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":12,"email":34},"Clinical Research Platform - Health Research Institut Biogipuzkoa","CONTACT","+34943006140","OSID.INVESTCLINICA@osakidetza.eus",[36,47,59],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":12,"geoPoint":12,"contacts":44},"Hospital Universitario Araba (HUA)","NOT_YET_RECRUITING","Vitoria - Gateiz","Araba","01009","Spain","ES",[45],{"name":46,"role":32,"phone":12,"phoneExt":12,"email":34},"Clinical Research Platform - Clinical Research Institute Biogipuzkoa",{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":42,"countryCode":43,"cosmosGeoPoint":53,"geoPoint":58,"contacts":12},"Hospital Universitario Galdakao (HUG)","ACTIVE_NOT_RECRUITING","Galdakao","Bizkaia","48960",{"type":54,"coordinates":55},"Point",[56,57],-2.8429,43.23073,{"lat":57,"lon":56},{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":42,"countryCode":43,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Hospital Universitario Donostia (HUD)","RECRUITING","San Sebastián","Guipuzcoa","20014",{"type":54,"coordinates":66},[67,68],-5.9,43.56667,{"lat":68,"lon":67},[71],{"name":46,"role":32,"phone":12,"phoneExt":12,"email":34},{"type":73,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100566843",false,"NCT06660446","Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.","Ejercicio Físico Durante El Tratamiento De Quimioterapia Como Programa Adyuvante En Pacientes Con Linfoma: Estudio EDONOLA","Inclusion Criteria:\n\n* Age: ≥18 years old.\n* Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.\n* Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.\n* Have a mobile phone to be able to contact the person and download the physical activity level app.\n* Eastern Cooperative Oncology Group performance status (ECOG) ≤2.\n* Life expectancy \\>12 months.\n* Availability and desire to participate throughout the study period.\n\nExclusion Criteria:\n\n* Have a contraindication to moderate-high intensity exercise.\n* Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac or pulmonary disorders that interfere with physical exercise; other malignant tumors in the last five years, with the exception of therapeutically controlled skin cancer; any other illness that may be seen affected or aggravated by physical exercise.\n* Have plans to be outside city more than two weeks.\n* People who are already physically active (that comply with the recommendations of WHO: \\> 150 minutes of exercise moderate\u002Fweekly, plus training force two days\u002Fweek).\n* Treatment based only with immunotherapy.\n* Central nervous system involvement due to lymphoma.\n* Have any important history that limit the capacity of the patient to participate in the study.","ALL","18 Years",{"count":83,"type":84},180,"ESTIMATED","INTERVENTIONAL",[87],"NA","In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. \u002F\u002F2.Reduce fatigue\u002F\u002F3.Reduce frailty\n\nThere is an association between some biological biomarkers with physical capacity and frailty.",[90],"Lymphoma",[90,92,93,94,95],"Physical Exercise","Fatigue","Cardiorespiratory capacity","Life Quality","2025-02-18",{"date":98,"type":99},"2025-02-19","ACTUAL",{"date":101,"type":99},"2024-10-08",{"date":103,"type":84},"2027-03-30",{"name":5,"class":6},3]